moclobemide has been researched along with Kidney Failure, Chronic in 1 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Excerpt | Relevance | Reference |
---|---|---|
" From these studies it can be concluded that, pharmacokinetically, neither age nor renal impairment require adjusting the dosage of moclobemide." | 1.28 | Absorption and disposition of moclobemide in patients with advanced age or reduced liver or kidney function. ( Andressen, C; Frey, F; Guentert, TW; Mayersohn, M; Ohnhaus, EE; Pfefen, JP; Schoerlin, MP; Stoeckel, K, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stoeckel, K | 1 |
Pfefen, JP | 1 |
Mayersohn, M | 1 |
Schoerlin, MP | 1 |
Andressen, C | 1 |
Ohnhaus, EE | 1 |
Frey, F | 1 |
Guentert, TW | 1 |
1 other study available for moclobemide and Kidney Failure, Chronic
Article | Year |
---|---|
Absorption and disposition of moclobemide in patients with advanced age or reduced liver or kidney function.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Benzamides; Female; Hum | 1990 |